SeekingAlpha · Sep 26, 2026
Guardian Pharmacy Services: Slowing Growth In H2 2026
Guardian Pharmacy Services trades at a premium forward EV/EBITDA versus BTSG, despite lower growth forecasts and guidance. Read why GRDN stock is a hold.
GR
NYSE · GRDN
Guardian Pharmacy Services, Inc.
Healthcare · Medical - Distribution
$41.20
Down-$0.90 (-2.14%)
Updated Oct 7, 2026, 4:27 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.98B
- P/E ratio
- 48.15
- Dividend yield
- 0.00%
- 52-week range
- $30.61 – $48.33
- Volume
- 388.56K
- Avg. volume
- 348.69K
Price performance · GRDN
GRDN price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
GRDN closed at $41.20 after 21 trading sessions, down 2.94% for the selected period.
- Last close
- $41.20
- Period change
- -2.94%
- Period low
- $40.68
- Period high
- $48.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $42.30 | $42.95 | $40.80 | $41.20 | 388.56K |
| Oct 5, 2026 | $42.60 | $42.74 | $42.08 | $42.10 | 276.03K |
| Oct 2, 2026 | $41.10 | $42.439 | $40.86 | $42.38 | 542.34K |
| Oct 1, 2026 | $40.66 | $41.245 | $40.04 | $40.84 | 498.14K |
| Sep 30, 2026 | $41.23 | $41.89 | $40.54 | $40.78 | 540.21K |
| Sep 29, 2026 | $40.48 | $40.89 | $40.19 | $40.68 | 488.22K |
| Sep 28, 2026 | $41.12 | $42.42 | $40.09 | $40.74 | 621.48K |
| Sep 25, 2026 | $41.70 | $42.34 | $41.19 | $41.21 | 720.62K |
| Sep 24, 2026 | $43.09 | $43.82 | $41.50 | $41.79 | 494.44K |
| Sep 23, 2026 | $44.65 | $45.07 | $43.17 | $43.26 | 440.77K |
| Sep 22, 2026 | $44.36 | $45.37 | $44.36 | $44.67 | 397.13K |
| Sep 21, 2026 | $45.14 | $45.14 | $43.34 | $44.16 | 570.32K |
| Sep 18, 2026 | $45.01 | $45.64 | $44.2401 | $44.99 | 3.21M |
| Sep 17, 2026 | $46.53 | $46.97 | $45.015 | $45.05 | 604.03K |
| Sep 16, 2026 | $47.57 | $48.33 | $45.19 | $46.52 | 836.81K |
| Sep 15, 2026 | $46.00 | $48.14 | $46.00 | $48.00 | 719.48K |
| Sep 14, 2026 | $43.50 | $46.815 | $43.50 | $46.49 | 925.87K |
| Sep 11, 2026 | $44.06 | $44.76 | $43.39 | $43.64 | 923.19K |
| Sep 10, 2026 | $43.23 | $44.55 | $42.87 | $43.83 | 698.58K |
| Sep 9, 2026 | $42.31 | $43.735 | $41.985 | $43.39 | 518.78K |
| Sep 8, 2026 | $40.61 | $42.63 | $40.0101 | $42.45 | 653.11K |
Latest GRDN news
The latest Smart Investors Daily articles mentioning GRDN.
Stock researchCompany · Overview
Company
Market Activity
Research & News
GRDN research
Overview
Company profile and research snapshot.
Company profile
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $32.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 23, 2026 | Keybanc | Overweight | — |
| Sep 21, 2026 | Truist Securities | Buy | — |
| Aug 7, 2026 | Oppenheimer | Outperform | — |
| Jun 17, 2026 | Truist Securities | Buy | — |
| Jun 17, 2026 | B of A Securities | Buy | — |
News briefing
No generated briefing is available yet.
Fintel · Sep 23, 2026
Keybanc Initiates Coverage of Guardian Pharmacy Services at Overweight
Benzinga · Sep 23, 2026
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Benzinga · Sep 23, 2026
Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52
Keybanc analyst Zach Haggerty initiates coverage on Guardian Pharmacy Service (NYSE:GRDN) with a Overweight rating and announces Price Target of $52.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
